[Pharmacology of heart failure-relevant substance groups].
Scholz
H
H
Abteilung Allgemeine Pharmakologie, Universitäts-Krankenhaus Eppendorf, Hamburg.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000493:pharmacokinetics / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D004232:Diuretics / Q000493:pharmacokinetics / Q000627:therapeutic use; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D014665:Vasodilator Agents / Q000493:pharmacokinetics / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D002301:Cardiac Glycosides; D002316:Cardiotonic Agents; D004232:Diuretics; D014665:Vasodilator Agents
Pharmakologie herzinsuffizienzrelevanter Substanzgruppen.